All lobbying filings

PRIME POLICY GROUP

PRIME POLICY GROUP filed a Q1 report for KEDRION BIOPHARMA on April 8, 2026, reporting $140,000 in lobbying income.

Lobbying for KEDRION BIOPHARMA · Production of Plasma-Derived Therapies

All filings by PRIME POLICY GROUP · Everything KEDRION BIOPHARMA has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 8, 2026

Income

$140,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Trade (domestic/foreign)

Pharmaceutical tariffs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem